Related Experiment Video

Updated: Aug 15, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Cardiac tamponade following pacemaker implantation

Clara Oliver Navarrete, Francisco Marín, Alejandro García Escrivá

    International Journal of Cardiology
    |September 28, 2005
    PubMed

    Insights

    Cardiac tamponade, a rare pacemaker complication, is increasingly caused by medical errors. This study reviews 17 years of center experience with these severe pericardial effusions.

    Area of Science:

    • Cardiology
    • Cardiac Surgery
    • Medical Device Complications

    Background:

    • Cardiac tamponade is a rare but serious complication following pacemaker implantation.
    • Iatrogenic causes are emerging as a significant factor contributing to severe pericardial effusions.
    • This study analyzes a 17-year experience from a single center.

    Discussion:

    • The incidence and management of iatrogenic cardiac tamponade post-pacemaker insertion require careful consideration.
    • Understanding the mechanisms of injury is crucial for prevention strategies.
    • Timely diagnosis and intervention are vital for patient outcomes.

    Key Insights:

    • Pacemaker implantation carries a risk of cardiac tamponade, often due to procedural complications.
    • Medical interventions (iatrogeny) are a growing cause of severe pericardial effusions.
    • A long-term institutional review highlights the persistent challenge of this complication.

    Outlook:

    • Further research into standardized procedural techniques may reduce iatrogenic tamponade.
    • Enhanced imaging and monitoring during pacemaker procedures could improve safety.
    • Continued vigilance and data collection are essential for refining patient care.

    More Related Videos

    Implantation of Total Artificial Heart in Congenital Heart Disease07:27

    Implantation of Total Artificial Heart in Congenital Heart Disease

    Published on: July 18, 2014

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

    Published on: February 17, 2018

    Related Concept Videos

    Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

    Cardiomyopathy VII: Pre and Post Operative Nursing Management

    Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
    Pericarditis IV: Nursing Management01:25

    Pericarditis IV: Nursing Management

    Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Pericarditis III: Medical Management01:17

    Pericarditis III: Medical Management

    The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...